Clinical Pharmacokinetics of Fluvoxamine

@article{Perucca1994ClinicalPO,
  title={Clinical Pharmacokinetics of Fluvoxamine},
  author={E. Perucca and G. Gatti and E. Spina},
  journal={Clinical Pharmacokinetics},
  year={1994},
  volume={27},
  pages={175-190}
}
SummaryFluvoxamine is a selective inhibitor of serotonin reuptake that is widely used in the management of depression.Following oral administration, the drug is absorbed efficiently from the gastrointestinal tract. Peak plasma concentrations are usually observed within 2 to 8 hours postdose for capsules and film-coated tablets and within 4 to 12 hours for enteric-coated tablets. Despite complete absorption, oral bioavailability may be incomplete probably because of first-pass metabolism… Expand
76 Citations
Inhibition of diazepam metabolism by fluvoxamine: A pharmacokinetic study in normal volunteers
  • 93
Pharmacokinetics of selective serotonin reuptake inhibitors.
  • 688
Non-linear fluvoxamine disposition.
  • 53
Pharmacokinetics of Fluvoxamine in Relation to CYP2C19 Phenotype and Genotype
  • 10
Metabolism and Pharmacokinetics of Selective Serotonin Reuptake Inhibitors
  • C. DeVane
  • Medicine
  • Cellular and Molecular Neurobiology
  • 2004
  • 137
  • Highly Influenced
Effects of Caffeine on the Kinetics of Fluvoxamine and its Major Metabolite in Plasma After a Single Oral Dose of the Drug
  • 5
  • Highly Influenced
Fluvoxamine. A review of global drug-drug interaction data.
  • 26
The Differential Effects of Steady‐State Fluvoxamine on the Pharmacokinetics of Olanzapine and Clozapine in Healthy Volunteers
  • 31
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
Inhibition of diazepam metabolism by fluvoxamine: A pharmacokinetic study in normal volunteers
  • 93
Review of the animal pharmacology and pharmacokinetics of fluvoxamine.
  • V. Claassen
  • Medicine
  • British journal of clinical pharmacology
  • 1983
  • 103
...
1
2
3
4
5
...